Barbara Weber, Director, Executive Chair at Tango Therapeutics, Inc. (TNGX), sold 61,038 shares at $12.26 ($749K) on 2026-02-03, disclosed to the SEC on 2026-02-04.
Open-market sale of $749k TNGX by Director, Executive Chair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.26 | 30,186 | $370K | 49.4% |
| 2 | $12.26 | 30,186 | $370K | 49.4% |
| 3 | $12.90 | 333 | $4K | 0.6% |
| 4 | $12.90 | 333 | $4K | 0.6% |
| Total | $12.27 avg | 61,038 | $749K | 100% |
| Filing → |
| TNGX | SELL | 2024-02-08 | $230K | — | Filing → |
| RVMD | SELL | 2023-09-06 | $526K | — | Filing → |
| RVMD | SELL | 2021-02-05 | $252K | — | Filing → |